首頁 > 市場調查報告書 > 醫療設備

整形外科美容整形

市場調查報告書

商品編碼

2071395

2026 年至 2035 年美容注射市場的機會、成長促進因素、產業趨勢分析與預測。

Aesthetic Injectables Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: 2026年06月03日 | 出版商:

Global Market Insights Inc. | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球注射化妝品市場預計到 2025 年將價值 126 億美元，並將以 10.3% 的複合年成長率成長，到 2035 年達到 333 億美元。

該市場的成長主要受全球對微創美容手術需求的不斷成長所驅動，與手術相比，微創美容手術恢復時間更短，效果更顯著。注射療法的日益普及反映了消費者對美容改善和預防性護膚意識的普遍提升。人口老化也顯著影響著市場需求，越來越多的人尋求解決皺紋、皮膚彈性喪失和臉部容量減少等問題。環境因素，例如污染、壓力和日曬損傷，進一步加劇了人們對美容矯正治療的需求。醫療機構、皮膚科診所和美容中心正在拓展服務範圍，引入先進的注射療法，並輔以不斷發展的技術。肉毒桿菌素製劑和皮膚填充劑仍然是主要產品類別，可用於減少皺紋、塑造臉部輪廓和恢復臉部容量。這些療法透過暫時放鬆目標肌肉、恢復臉部飽滿度和刺激膠原膠原蛋白生成，從而改善臉部對稱性和年輕化效果。總體而言，由於技術進步、可支配收入增加以及全球對非手術美容療法的接受度不斷提高，該市場將持續擴張。

市場範圍
開始年份	2025
預測期	2026-2035
起始金額	126億美元
預測金額	333億美元
複合年成長率	10.3%

預計到2035年，皮膚填充劑市場規模將達到193億美元，主要得益於消費者對非侵入性臉部年輕化療法的強勁需求。市場持續成長的原因在於其在改善臉部容量流失、撫平皺紋和提升臉部輪廓方面的顯著效果。皮膚填充劑因其安全性高、效果可預測且用途廣泛，在美容醫學領域已廣泛應用。消費者對微創手術的日益青睞也進一步推動了市場擴張。

到2025年，女性將佔據85.7%的市場佔有率，這主要得益於她們對美容治療的認知度不斷提高以及對美容手術的早期接受。女性仍然是注射美容療程的主要消費群體，她們尋求的治療旨在減少皺紋、改善臉部輪廓並預防早期老化徵兆。人們對自身形象、自我護理和專業形像日益成長的關注，推動了各個年齡層消費者的需求，從尋求預防保健的年輕消費者到尋求抗衰老方案的年長消費者，都對注射美容治療趨之若鶓。

預計到2025年，北美注射美容市場銷售額將達到65億美元，到2035年將達到157億美元，複合年成長率（CAGR）為9.3%。該地區保持其市場主導地位，主要得益於對選擇性美容手術的強勁需求、先進的醫療基礎設施以及大量技術精湛的美容醫療專業人員。創新注射療法的廣泛應用和新型美容技術的快速發展進一步推動了市場成長。將注射療法與其他輔助美容手術相結合的聯合治療的日益普及，也促進了該地區市場的擴張。

產業生態系分析
影響產業的因素
- 成長促進因素
  - 對微創美容手術的需求日益成長
  - 人口老化和人們對美的日益關注
  - 社群媒體和美學意識日益增強的影響力
  - 擴大認證美容師的數量
- 產業潛在風險與挑戰
  - 美容注射療法高成本
  - 副作用和併發症的風險
- 市場機遇
  - 開發作用時間更長、更安全的注射劑
  - 男性消費者使用範圍擴大
成長潛力分析
技術展望
- 目前技術
- 新興技術
價格分析
監理情勢
品牌分析
波特的分析
PESTLE分析
未來市場趨勢
人工智慧和生成式人工智慧對市場的影響

第4章競爭情勢

介紹
企業市佔率分析
- 北美洲
- 歐洲
- 亞太地區
企業矩陣分析
主要市場公司的競爭分析
競爭定位矩陣
主要進展
- 併購
- 夥伴關係和聯盟
- 新產品發布

第5章市場估計與預測：依類型分類，2022-2035年

肉毒桿菌毒素
- A型肉毒桿菌毒素
- B型肉毒桿菌
皮膚填充劑
- 產品類型
  - 玻尿酸
  - 羥磷石灰鈣
  - 聚左旋乳酸
  - 聚甲基丙烯酸甲酯（PMMA）微球
  - 膠原蛋白
  - 脂肪填充物
  - 其他皮膚填充劑
- 目的
  - 拉皮
  - 臉部矯正
  - 改善皺紋
  - 痤瘡疤痕
  - 脂肪萎縮
  - 唇部豐盈度增加
  - 髖關節增大手術
  - 隆乳
  - 手部回春手術
  - 陰莖增大
  - 眼瞼成形術
  - 頸部和下巴提拉術
  - 其他用途

第6章市場估計與預測：依性別分類，2022-2035年

女士
男性

第7章市場估計與預測：依年齡層別分類，2022-2035年

15-30歲
31-40歲
41-50歲
51-60歲
60歲以上

第8章市場估算與預測：依最終用途分類，2022-2035年

醫院
皮膚科診所
其他最終用戶

第9章市場估計與預測：依地區分類，2022-2035年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- UAE

第10章：公司簡介

AbbVie Inc（Allergan Aesthetics）
Bio-Med
Bioxis Pharmaceuticals
Cytophil
Galderma
Ipsen
Laboratories Vivacy
Merz Pharma
Mesoestetic
Sinclair Pharma
Suneva Medical
Teoxane Laboratories

簡介目錄

Product Code: 8040

The Global Aesthetic Injectables Market was valued at USD 12.6 billion in 2025 and is estimated to grow at a CAGR of 10.3% to reach USD 33.3 billion by 2035.

Growth in this market is driven by the rising global preference for minimally invasive cosmetic procedures that deliver visible results with reduced recovery time compared to surgical alternatives. Increasing adoption of injectable treatments reflects a broader shift in consumer attitudes toward aesthetic enhancement and preventive skin care. The growing aging population is also significantly influencing demand, as individuals seek solutions for wrinkles, reduced skin elasticity, and facial volume loss. Environmental factors such as pollution exposure, stress, and sun damage are further accelerating the need for corrective aesthetic treatments. Healthcare providers, dermatology clinics, and cosmetic centers are expanding their service portfolios to include advanced injectable procedures supported by evolving technologies. Botulinum toxin products and dermal fillers remain the primary categories, offering solutions for wrinkle reduction, facial contouring, and volume restoration. These treatments work by temporarily relaxing targeted muscles, restoring facial fullness, and stimulating collagen activity, resulting in improved facial symmetry and rejuvenation outcomes. Overall, the market continues to expand due to technological progress, rising disposable income, and increasing acceptance of non-surgical cosmetic enhancements globally.

Market Scope
Start Year	2025
Forecast Year	2026-2035
Start Value	$12.6 Billion
Forecast Value	$33.3 Billion
CAGR	10.3%

The dermal fillers segment is projected to reach USD 19.3 billion by 2035, supported by strong demand for non-invasive facial rejuvenation procedures. This segment continues to grow due to its effectiveness in addressing volume loss, smoothing wrinkles, and enhancing facial contours. Dermal fillers are widely adopted across aesthetic practices due to their strong safety profile, predictable outcomes, and versatility in cosmetic applications. Increasing preference for minimally invasive procedures further reinforces their market expansion.

The female segment accounted for 85.7% of the total market share in 2025, driven by higher awareness of aesthetic treatments and early adoption of cosmetic enhancement procedures. Women remain the primary consumer base for injectable aesthetics, utilizing treatments for wrinkle reduction, facial contour improvement, and prevention of early aging signs. Growing focus on personal appearance, self-care routines, and professional presentation continues to expand demand across various age groups, from younger consumers seeking preventive care to older populations pursuing rejuvenation solutions.

North America Aesthetic Injectables Market with revenue of USD 6.5 billion in 2025 and is expected to reach USD 15.7 billion by 2035, growing at a CAGR of 9.3%. The region maintains its dominance due to strong demand for elective cosmetic procedures, advanced healthcare infrastructure, and a high concentration of skilled aesthetic practitioners. Widespread availability of innovative injectable treatments and rapid adoption of new aesthetic technologies further strengthen market growth. The increasing popularity of combination therapies involving injectables and complementary cosmetic procedures continues to support regional expansion.

Key companies operating in the global aesthetic injectables market include Galderma, AbbVie Inc (Allergan Aesthetics), Merz Pharma, Ipsen, Sinclair Pharma, Teoxane Laboratories, Bio-Med, Bioxis Pharmaceuticals, Cytophil, Laboratoires Vivacy, Suneva Medical, and Mesoestetic. Companies in the aesthetic injectables market are adopting a range of strategic initiatives to strengthen their competitive positioning and expand global reach. A primary focus is placed on continuous product innovation, particularly in developing advanced formulations with improved safety profiles, longer-lasting effects, and enhanced precision. Firms are heavily investing in research and development to introduce next-generation botulinum toxins and dermal fillers. Strategic collaborations with dermatology clinics, aesthetic centers, and healthcare professionals are helping companies expand treatment accessibility and brand trust. Expanding geographic presence through emerging markets is another key strategy, supported by localized distribution networks. Companies are also strengthening their marketing efforts through digital engagement, influencer partnerships, and educational campaigns to raise awareness of aesthetic treatments.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research approach
1.3 Quality commitments
- 1.3.1 GMI AI policy and data integrity commitment
  - 1.3.1.1 Source consistency protocol
1.4 Research trail and confidence scoring
- 1.4.1 Research trail components
- 1.4.2 Scoring components
1.5 Data collection
- 1.5.1 Partial list of primary sources
1.6 Data mining sources
- 1.6.1 Paid sources
  - 1.6.1.1 Sources, by region
1.7 Base estimates and calculations
- 1.7.1 Revenue share analysis
- 1.7.2 Base year calculation
1.8 Forecast model
1.9 Research transparency addendum
- 1.9.1 Source attribution framework
- 1.9.2 Quality assurance metrics
- 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

2.1 Industry 360° synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Type trends
- 2.2.3 Gender trends
- 2.2.4 Age group trends
- 2.2.5 End use trends
2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising demand for minimally invasive cosmetic procedures
  - 3.2.1.2 Increasing aging population and beauty consciousness
  - 3.2.1.3 Growing influence of social media and aesthetic awareness
  - 3.2.1.4 Expanding availability of certified aesthetic practitioners
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of aesthetic injectable procedures
  - 3.2.2.2 Risk of side effects and complications
- 3.2.3 Market opportunities
  - 3.2.3.1 Development of longer-lasting and safer injectables
  - 3.2.3.2 Increasing adoption among male consumers
3.3 Growth potential analysis
3.4 Technology landscape
- 3.4.1 Current technology
- 3.4.2 Emerging technologies
3.5 Pricing Analysis (Driven by Primary Research)
3.6 Regulatory landscape (Driven by primary research)
- 3.6.1 North America
- 3.6.2 Europe
- 3.6.3 Asia Pacific
- 3.6.4 Latin America
- 3.6.5 MEA
3.7 Brand analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends (Driven by primary research)
3.11 Impact of AI and generative AI on the market

Chapter 4 Competitive Landscape, 2025

4.1 Introduction
4.2 Company market share analysis
- 4.2.1 North America
- 4.2.2 Europe
- 4.2.3 Asia Pacific
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Merger and acquisition
- 4.6.2 Partnership and collaboration
- 4.6.3 New product launches

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

5.1 Key trends
5.2 Botulinum toxin
- 5.2.1 Botulinum toxin A
- 5.2.2 Botulinum toxin B
5.3 Dermal fillers
- 5.3.1 Product type
  - 5.3.1.1 Hyaluronic acid
  - 5.3.1.2 Calcium hydroxylapatite
  - 5.3.1.3 Poly-L-lactic acid
  - 5.3.1.4 Polymethyl-methacrylate microspheres (PMMA)
  - 5.3.1.5 Collagen
  - 5.3.1.6 Fat fillers
  - 5.3.1.7 Other dermal fillers
- 5.3.2 Application
  - 5.3.2.1 Face lift
  - 5.3.2.2 Facial correction
  - 5.3.2.3 Wrinkles reduction
  - 5.3.2.4 Acne scar
  - 5.3.2.5 Lipoatrophy
  - 5.3.2.6 Lip enhancement
  - 5.3.2.7 Hip augmentation
  - 5.3.2.8 Breast enhancement
  - 5.3.2.9 Hand rejuvenation
  - 5.3.2.10 Penis enlargement
  - 5.3.2.11 Blepharoplasty
  - 5.3.2.12 Neck & chin lift
  - 5.3.2.13 Other applications

Chapter 6 Market Estimates and Forecast, By Gender, 2022 - 2035 ($ Mn)

6.1 Key trends
6.2 Female
6.3 Male

Chapter 7 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)

7.1 Key trends
7.2 15-30
7.3 31-40
7.4 41-50
7.5 51-60
7.6 >60

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Dermatology clinics
8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE